Jian Ping Gu
Chairman at Jiangsu Xiangtang Group Co., Ltd.
Net worth: 46 M $ as of 2024-05-30
Network origin in Jian Ping Gu first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 7 | |
Zhaoyan (Suzhou) New Drug Research Center Co. Ltd.
2
| Subsidiary | 2 | |
Suzhou Xiangtang Guarantee Co. Ltd.
2
| Subsidiary | 2 | |
Jiangsu Xiangtang Group Co., Ltd.
1
| Subsidiary | 1 | |
Suzhou Pingjing Trading Co. Ltd.
1
| Private Company | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Jian Ping Gu via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| China Europe International Business School | College/University | Masters Business Admin | |
InflaRx GmbH
 InflaRx GmbH BiotechnologyHealth Technology InflaRx GmbH operates as a biotech company which develops new therapeutics in the field of inflammation. It focuses on the general area of inflammation including indications such as SIRS and SEPSIS by applying innovative therapeutics in order to prevent organ dysfunction or limit progression into organ failure. The firm's complement system is activated and produces large amounts of products including complement 5a (C5a), C3a, C4a and membrane-attack complex (MAC). The company was founded in 2007 by Niels Riedemann and Renfeng Guo and is headquartered in Jena, Germany. | Biotechnology | Director/Board Member | |
| Southern Medical University | College/University | Doctorate Degree | |
Vector Gene Technology Co. Ltd.
 Vector Gene Technology Co. Ltd. Pharmaceuticals: MajorHealth Technology Vector Gene Technology Co. Ltd. is a Chinese company that manufactures and distributes pharmaceutical products. | Pharmaceuticals: Major | President | |
HKU School of Professional & Continuing Education
 HKU School of Professional & Continuing Education Other Consumer ServicesConsumer Services University of Hong Kong School of Professional and Continuing Education engages in the educational services. It providing learning opportunities for personal, professional and career advancement for people from all walks of life. The company was founded in 1957 and is headquartered in Hong Kong. | College/University | Masters Business Admin | |
| Foshan Kangbaoshun Pharmaceutical Co. Ltd. | Corporate Officer/Principal | ||
| Chinese PLA Academy of Military Medical Sciences | College/University | Graduate Degree Graduate Degree | |
| Beijing Joinn New Drug Research Center | Corporate Officer/Principal Corporate Officer/Principal | ||
| Beijing Sannuo Jiayi Biotechnology Co. Ltd. | Chairman President | ||
| Shanghai Xiangtang Investment Co. Ltd. | Chairman | ||
| Chinese Peoples Liberation Army 251 Hospital | Corporate Officer/Principal | ||
| Beijing Zhaoyan Bona New Drug Research Co. Ltd. | Chairman | ||
| Jiangsu Xiangtang Construction & Investment Co. Ltd. | Chairman | ||
Hunan Zhongwei Pharmaceutical Co. Ltd.
 Hunan Zhongwei Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Hunan Zhongwei Pharmaceutical Co. Ltd. is a Chinese company that manufactures pharmaceutical products. | Pharmaceuticals: Major | Director/Board Member | |
| Beijing Zhaoyan New Drug Research Center Co. Ltd. | Director/Board Member Director/Board Member | ||
| Jiangsu Xiangtang Investment Development Co. Ltd. | Director/Board Member | ||
| Jiangsu Xiangtang Group Import & Export Co. Ltd. | Chairman | ||
Taicang Zhenhui Chemical Fiber Co. Ltd.
 Taicang Zhenhui Chemical Fiber Co. Ltd. Chemicals: Major DiversifiedProcess Industries Part of Jiangsu Xiangtang Group Co., Ltd., Taicang Zhenhui Chemical Fiber Co. Ltd. is a Chinese company that manufactures chemical fiber products. The company is based in Suzhou, China. | Chemicals: Major Diversified | Chairman | |
| Suzhou Xiangtang Assets Supervision Co. Ltd. | Chairman | ||
| Shandong Academy of Medical Science | College/University | Undergraduate Degree | |
| Hunan University of Chinese Medicine | College/University | Undergraduate Degree | |
Yizhao (Beijing) Pharmaceutical Technology Co., Ltd.
 Yizhao (Beijing) Pharmaceutical Technology Co., Ltd. Financial ConglomeratesFinance Yizhao (Beijing) Pharmaceutical Technology Co., Ltd. engages in the technology development of pharmaceuticals. It also provides technical consulting and market research services. The company was founded on August 21, 2008 and is headquartered in Beijing, China. | Financial Conglomerates | Director/Board Member Chairman Director/Board Member | |
| JOINN LABORATORIES(CHINA)CO.,LTD. | Biotechnology | Corporate Officer/Principal | |
Salubris (Suzhou) Pharmaceuticals Co., Ltd.
 Salubris (Suzhou) Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Salubris (Suzhou) Pharmaceuticals Co., Ltd. engages in the research and development of biotechnology products. The company was founded on September 20, 2010 and is headquartered in Taicang, China. | Biotechnology | Director/Board Member | |
| INFLARX N.V. | Biotechnology | Director/Board Member | |
Zhejiang Staidson Investment Co., Ltd.
 Zhejiang Staidson Investment Co., Ltd. Investment ManagersFinance Zhejiang Staidson Investment Co., Ltd. engages in investment industry. It services include Industrial Investment, Investment Management, Investment Consulting, and Business Management Consulting. The company was founded on June 27, 2017 and is headquartered in Zhejiang, China. | Investment Managers | Chief Executive Officer Director/Board Member Director/Board Member | |
| Beijing Defengrei Biotechnology Co. Ltd. | Chairman | ||
Staidson Biopharma, Inc.
 Staidson Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Staidson Biopharma, Inc. is an American company that focuses on researching and developing biotechnology. | Miscellaneous Commercial Services | Corporate Secretary | |
Staidson Hong Kong Investment Co. Ltd.
 Staidson Hong Kong Investment Co. Ltd. Investment ManagersFinance Part of Staidson (Beijing) Biopharmaceuticals Co., Ltd., Staidson Hong Kong Investment Co. Ltd. provides asset management services. The company is based in Hong Kong, Hong Kong. Li Na Ma has been the CEO of the Chinese company since 2015. | Investment Managers | Chief Executive Officer | |
| SICHUAN HUIYU PHARMACEUTICAL CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
Suzhou Nuojiebei Biotechnology Co., Ltd.
 Suzhou Nuojiebei Biotechnology Co., Ltd. BiotechnologyHealth Technology Suzhou Nuojiebei Biotechnology Co. Ltd. develops gene therapy drugs for genetic diseases. The company is located in China. | Biotechnology | Founder |
Statistics
International
| China | 27 |
| Germany | 3 |
| Hong Kong | 3 |
| United States | 2 |
Sectoral
| Health Technology | 9 |
| Consumer Services | 7 |
| Finance | 4 |
| Process Industries | 2 |
| Commercial Services | 2 |
Operational
| Director/Board Member | 23 |
| Chairman | 12 |
| Corporate Officer/Principal | 9 |
| President | 6 |
| Corporate Secretary | 5 |
Most connected contacts
| Insiders | |
|---|---|
| Zhen Qi Gu | 12 |
| Li Na Ma | 11 |
| Zhi Wen Zhou | 10 |
| Hong Shan Zhang | 6 |
| Li Xin Jiang | 5 |
| Hai Yan Cao | 3 |
| Tao Li | 3 |
| Rong Qin Zhang | 3 |
- Stock Market
- Insiders
- Jian Ping Gu
- Company connections
